Wisderm.com
Open menu
Concerns
Interventions
Latest Research
FAQ
4-n-butylresorcinol dissolving microneedle patch for skin depigmentation: a randomized, double-blind, placebo-controlled trial
Study Design
Subject Type
Human
Trial Design
Double-Blind, Randomised, Controlled
Trial Duration
56 days
Participants
126
Efficacy
Intervention(s)
Outcome
Method
Effect
Description
Rucinol
Skin Brightness
Mexameter
🠩
Sign in to read for free
Sign in to read for free
Rucinol
Skin Brightness
Mexameter
–
Sign in to read for free
Sign in to read for free
Mechanisms
Intervention(s)
Outcome
Method
Effect
Description
Rucinol
Melanin
Mexameter
🠫
Sign in to read for free
Sign in to read for free
Rucinol
Melanin
Mexameter
🠫
Sign in to read for free
Sign in to read for free
Side Effects
Intervention(s)
Outcome
Effect
Description
Rucinol
Contact Dermatitis
–
Sign in to read for free
Sign in to read for free
Rucinol
Irritation
⇧
Sign in to read for free
Sign in to read for free
Study Summary
Sign in to read for free